Abbott Laboratories

ABTNYSEUSD
87.36 USD
0.39 (0.45%)🟢LIVE (AS OF 12:05 PM EDT)
🟢Market: OPEN
Open?$87.20
High?$87.99
Low?$86.75
Prev. Close?$86.97
Volume?3.6M
Avg. Volume?12.8M
VWAP?$87.40
Rel. Volume?0.28x
Bid / Ask
Bid?$87.12 × 100
Ask?$87.16 × 100
Spread?$0.04
Midpoint?$87.14
Valuation & Ratios
Market Cap?151.5B
Shares Out?1.7B
Float?1.7B
Float %?99.5%
P/E Ratio?24.14
P/B Ratio?2.91
EPS?$3.60
Dividend?2.76%
Ex-Dividend?N/A

ABT is currently priced at $87.36. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a weak Piotroski F-Score of 2/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, ABT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 2, 2026.

News
Profile
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Employees
115.0K
Market Cap
152.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-19
Address
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
Phone: (224) 667-6100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
69
Momentum?
60
Short Sent.?
84
Piotroski F-Score?2/9Weak
Altman Z-Score?2.92Grey
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.34%Low
Short Interest?23.2M
Days to Cover?1.7
Free Float1.7B
Avg Daily Volume13.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.39Adequate
Quick Ratio?1.01Adequate
Cash Ratio?0.37Low
Debt/Equity?0.65Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
72/100
P/E?
Peers
64
S&P
50
24.1FAIR
P/B?
Peers
60
S&P
57
2.91CHEAP
P/S?
Peers
73
S&P
46
3.36FAIR
P/FCF?
Peers
55
S&P
53
20.5FAIR
EV/EBITDA?
Peers
55
S&P
40
16.5FAIR
EV/Sales?
Peers
64
S&P
47
3.96FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
43
12.1%STRONG
ROA?
Peers
55
S&P
51
5.7%FAIR
Cash Flow & Enterprise
FCF?$7.4B
Enterprise Value?$178.7B
Fundamentals ratios updated end of day